1 Female Infertility Drugs Market Overview 1.1 Product Overview and Scope of Female Infertility Drugs 1.2 Female Infertility Drugs Segment by Type 1.2.1 Global Female Infertility Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Parenteral 1.2.3 Oral 1.2.4 Others 1.3 Female Infertility Drugs Segment by Application 1.3.1 Global Female Infertility Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Fertility Clinics 1.3.3 Hospitals 1.3.4 Cryobanks 1.4 Global Female Infertility Drugs Market Size Estimates and Forecasts 1.4.1 Global Female Infertility Drugs Revenue 2017-2028 1.4.2 Global Female Infertility Drugs Sales 2017-2028 1.4.3 Female Infertility Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Female Infertility Drugs Market Competition by Manufacturers 2.1 Global Female Infertility Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Female Infertility Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Female Infertility Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Female Infertility Drugs Manufacturing Sites, Area Served, Product Type 2.5 Female Infertility Drugs Market Competitive Situation and Trends 2.5.1 Female Infertility Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Female Infertility Drugs Players Market Share by Revenue 2.5.3 Global Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Female Infertility Drugs Retrospective Market Scenario by Region 3.1 Global Female Infertility Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Female Infertility Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Female Infertility Drugs Market Facts & Figures by Country 3.3.1 North America Female Infertility Drugs Sales by Country 3.3.2 North America Female Infertility Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Female Infertility Drugs Market Facts & Figures by Country 3.4.1 Europe Female Infertility Drugs Sales by Country 3.4.2 Europe Female Infertility Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Female Infertility Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Female Infertility Drugs Sales by Region 3.5.2 Asia Pacific Female Infertility Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Female Infertility Drugs Market Facts & Figures by Country 3.6.1 Latin America Female Infertility Drugs Sales by Country 3.6.2 Latin America Female Infertility Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Female Infertility Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Female Infertility Drugs Sales by Country 3.7.2 Middle East and Africa Female Infertility Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Female Infertility Drugs Historic Market Analysis by Type 4.1 Global Female Infertility Drugs Sales Market Share by Type (2017-2022) 4.2 Global Female Infertility Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Female Infertility Drugs Price by Type (2017-2022) 5 Global Female Infertility Drugs Historic Market Analysis by Application 5.1 Global Female Infertility Drugs Sales Market Share by Application (2017-2022) 5.2 Global Female Infertility Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Female Infertility Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Allergan Plc 6.1.1 Allergan Plc Corporation Information 6.1.2 Allergan Plc Description and Business Overview 6.1.3 Allergan Plc Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Allergan Plc Female Infertility Drugs Product Portfolio 6.1.5 Allergan Plc Recent Developments/Updates 6.2 Ferring BV 6.2.1 Ferring BV Corporation Information 6.2.2 Ferring BV Description and Business Overview 6.2.3 Ferring BV Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Ferring BV Female Infertility Drugs Product Portfolio 6.2.5 Ferring BV Recent Developments/Updates 6.3 Merck KGaA 6.3.1 Merck KGaA Corporation Information 6.3.2 Merck KGaA Description and Business Overview 6.3.3 Merck KGaA Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Merck KGaA Female Infertility Drugs Product Portfolio 6.3.5 Merck KGaA Recent Developments/Updates 6.4 Novartis AG 6.4.1 Novartis AG Corporation Information 6.4.2 Novartis AG Description and Business Overview 6.4.3 Novartis AG Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Novartis AG Female Infertility Drugs Product Portfolio 6.4.5 Novartis AG Recent Developments/Updates 6.5 Sanofi 6.5.1 Sanofi Corporation Information 6.5.2 Sanofi Description and Business Overview 6.5.3 Sanofi Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Sanofi Female Infertility Drugs Product Portfolio 6.5.5 Sanofi Recent Developments/Updates 7 Female Infertility Drugs Manufacturing Cost Analysis 7.1 Female Infertility Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Female Infertility Drugs 7.4 Female Infertility Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Female Infertility Drugs Distributors List 8.3 Female Infertility Drugs Customers 9 Female Infertility Drugs Market Dynamics 9.1 Female Infertility Drugs Industry Trends 9.2 Female Infertility Drugs Market Drivers 9.3 Female Infertility Drugs Market Challenges 9.4 Female Infertility Drugs Market Restraints 10 Global Market Forecast 10.1 Female Infertility Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Female Infertility Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Female Infertility Drugs by Type (2023-2028) 10.2 Female Infertility Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Female Infertility Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Female Infertility Drugs by Application (2023-2028) 10.3 Female Infertility Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Female Infertility Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Female Infertility Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Female Infertility Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Female Infertility Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Female Infertility Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Female Infertility Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Female Infertility Drugs Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Female Infertility Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Female Infertility Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Female Infertility Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Female Infertility Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Female Infertility Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Female Infertility Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Female Infertility Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Female Infertility Drugs Sales by Region (2017-2022) & (K Units) Table 16. Global Female Infertility Drugs Sales Market Share by Region (2017-2022) Table 17. Global Female Infertility Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Female Infertility Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Female Infertility Drugs Sales by Country (2017-2022) & (K Units) Table 20. North America Female Infertility Drugs Sales Market Share by Country (2017-2022) Table 21. North America Female Infertility Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Female Infertility Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Female Infertility Drugs Sales by Country (2017-2022) & (K Units) Table 24. Europe Female Infertility Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Female Infertility Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Female Infertility Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Female Infertility Drugs Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Female Infertility Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Female Infertility Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Female Infertility Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Female Infertility Drugs Sales by Country (2017-2022) & (K Units) Table 32. Latin America Female Infertility Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Female Infertility Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Female Infertility Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Female Infertility Drugs Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Female Infertility Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Female Infertility Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Female Infertility Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Female Infertility Drugs Sales by Type (2017-2022) & (K Units) Table 40. Global Female Infertility Drugs Sales Market Share by Type (2017-2022) Table 41. Global Female Infertility Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Female Infertility Drugs Revenue Share by Type (2017-2022) Table 43. Global Female Infertility Drugs Price by Type (2017-2022) & (USD/Unit) Table 44. Global Female Infertility Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Female Infertility Drugs Sales Market Share by Application (2017-2022) Table 46. Global Female Infertility Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Female Infertility Drugs Revenue Share by Application (2017-2022) Table 48. Global Female Infertility Drugs Price by Application (2017-2022) & (USD/Unit) Table 49. Allergan Plc Corporation Information Table 50. Allergan Plc Description and Business Overview Table 51. Allergan Plc Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Allergan Plc Female Infertility Drugs Product Table 53. Allergan Plc Recent Developments/Updates Table 54. Ferring BV Corporation Information Table 55. Ferring BV Description and Business Overview Table 56. Ferring BV Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Ferring BV Female Infertility Drugs Product Table 58. Ferring BV Recent Developments/Updates Table 59. Merck KGaA Corporation Information Table 60. Merck KGaA Description and Business Overview Table 61. Merck KGaA Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Merck KGaA Female Infertility Drugs Product Table 63. Merck KGaA Recent Developments/Updates Table 64. Novartis AG Corporation Information Table 65. Novartis AG Description and Business Overview Table 66. Novartis AG Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Novartis AG Female Infertility Drugs Product Table 68. Novartis AG Recent Developments/Updates Table 69. Sanofi Corporation Information Table 70. Sanofi Description and Business Overview Table 71. Sanofi Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Sanofi Female Infertility Drugs Product Table 73. Sanofi Recent Developments/Updates Table 74. Production Base and Market Concentration Rate of Raw Material Table 75. Key Suppliers of Raw Materials Table 76. Female Infertility Drugs Distributors List Table 77. Female Infertility Drugs Customers List Table 78. Female Infertility Drugs Market Trends Table 79. Female Infertility Drugs Market Drivers Table 80. Female Infertility Drugs Market Challenges Table 81. Female Infertility Drugs Market Restraints Table 82. Global Female Infertility Drugs Sales Forecast by Type (2023-2028) & (K Units) Table 83. Global Female Infertility Drugs Sales Market Share Forecast by Type (2023-2028) Table 84. Global Female Infertility Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 85. Global Female Infertility Drugs Revenue Market Share Forecast by Type (2023-2028) Table 86. Global Female Infertility Drugs Sales Forecast by Application (2023-2028) & (K Units) Table 87. Global Female Infertility Drugs Sales Market Share Forecast by Application (2023-2028) Table 88. Global Female Infertility Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 89. Global Female Infertility Drugs Revenue Market Share Forecast by Application (2023-2028) Table 90. Global Female Infertility Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 91. Global Female Infertility Drugs Sales Market Share Forecast by Region (2023-2028) Table 92. Global Female Infertility Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 93. Global Female Infertility Drugs Revenue Market Share Forecast by Region (2023-2028) Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Female Infertility Drugs Figure 2. Global Female Infertility Drugs Market Share by Type in 2021 & 2028 Figure 3. Parenteral Product Picture Figure 4. Oral Product Picture Figure 5. Others Product Picture Figure 6. Global Female Infertility Drugs Market Share by Application in 2021 & 2028 Figure 7. Fertility Clinics Figure 8. Hospitals Figure 9. Cryobanks Figure 10. Global Female Infertility Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Female Infertility Drugs Market Size (2017-2028) & (US$ Million) Figure 12. Global Female Infertility Drugs Sales (2017-2028) & (K Units) Figure 13. Female Infertility Drugs Sales Share by Manufacturers in 2021 Figure 14. Global Female Infertility Drugs Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Female Infertility Drugs Players: Market Share by Revenue in 2021 Figure 16. Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Female Infertility Drugs Sales Market Share by Region (2017-2022) Figure 18. Global Female Infertility Drugs Sales Market Share by Region in 2021 Figure 19. Global Female Infertility Drugs Revenue Market Share by Region (2017-2022) Figure 20. Global Female Infertility Drugs Revenue Market Share by Region in 2021 Figure 21. U.S. Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. U.A.E Female Infertility Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Female Infertility Drugs by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Female Infertility Drugs Figure 47. Manufacturing Process Analysis of Female Infertility Drugs Figure 48. Female Infertility Drugs Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Allergan Plc Ferring BV Merck KGaA Novartis AG Sanofi